A carregar...
Thrombocytosis in patients with pancreatic cancer treated with gemcitabine – does it have clinical significance? Description of 6 cases
Gemcitabine is a cytostatic drug from the pyrimidine antimetabolite group. It is used in treatment of some neoplasms, among them inoperable pancreatic cancer. The most common undesirable effects of gemcitabine include pancytopenia, with thrombocytopenia associated with gemcitabine's myelosuppre...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Termedia Publishing House
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3687435/ https://ncbi.nlm.nih.gov/pubmed/23788909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2012.30068 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|